SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-046860
Filing Date
2024-11-12
Accepted
2024-11-12 07:35:35
Documents
47
Period of Report
2024-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K syre-20241112.htm   iXBRL 8-K 52889
2 EX-99.1 exhibit991-8xkdatarelease.htm EX-99.1 27761
3 EX-99.2 exhibit992-8xkdatareleas.htm EX-99.2 32983
7 exhibit992-8xkdatareleas001.jpg GRAPHIC 77151
8 exhibit992-8xkdatareleas002.jpg GRAPHIC 284474
9 exhibit992-8xkdatareleas003.jpg GRAPHIC 85904
10 exhibit992-8xkdatareleas004.jpg GRAPHIC 95564
11 exhibit992-8xkdatareleas005.jpg GRAPHIC 89434
12 exhibit992-8xkdatareleas006.jpg GRAPHIC 121185
13 exhibit992-8xkdatareleas007.jpg GRAPHIC 112840
14 exhibit992-8xkdatareleas008.jpg GRAPHIC 67277
15 exhibit992-8xkdatareleas009.jpg GRAPHIC 128939
16 exhibit992-8xkdatareleas010.jpg GRAPHIC 64094
17 exhibit992-8xkdatareleas011.jpg GRAPHIC 99083
18 exhibit992-8xkdatareleas012.jpg GRAPHIC 91802
19 exhibit992-8xkdatareleas013.jpg GRAPHIC 92599
20 exhibit992-8xkdatareleas014.jpg GRAPHIC 94101
21 exhibit992-8xkdatareleas015.jpg GRAPHIC 89451
22 exhibit992-8xkdatareleas016.jpg GRAPHIC 128898
23 exhibit992-8xkdatareleas017.jpg GRAPHIC 103663
24 exhibit992-8xkdatareleas018.jpg GRAPHIC 81369
25 exhibit992-8xkdatareleas019.jpg GRAPHIC 106407
26 exhibit992-8xkdatareleas020.jpg GRAPHIC 65019
27 exhibit992-8xkdatareleas021.jpg GRAPHIC 111586
28 exhibit992-8xkdatareleas022.jpg GRAPHIC 139504
29 exhibit992-8xkdatareleas023.jpg GRAPHIC 134548
30 exhibit992-8xkdatareleas024.jpg GRAPHIC 93666
31 exhibit992-8xkdatareleas025.jpg GRAPHIC 62737
32 exhibit992-8xkdatareleas026.jpg GRAPHIC 124859
33 exhibit992-8xkdatareleas027.jpg GRAPHIC 93682
34 exhibit992-8xkdatareleas028.jpg GRAPHIC 121675
35 exhibit992-8xkdatareleas029.jpg GRAPHIC 89500
36 exhibit992-8xkdatareleas030.jpg GRAPHIC 88724
37 exhibit992-8xkdatareleas031.jpg GRAPHIC 53026
38 spyrelogo.jpg GRAPHIC 57837
  Complete submission text file 0001628280-24-046860.txt   4750891

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syre-20241112.xsd EX-101.SCH 1777
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syre-20241112_lab.xml EX-101.LAB 23471
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syre-20241112_pre.xml EX-101.PRE 13584
49 EXTRACTED XBRL INSTANCE DOCUMENT syre-20241112_htm.xml XML 2928
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 241443342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)